These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11858905

  • 1. In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.
    Casellas JM, Tomé G, Visser M, Gliosca L.
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):107-12. PubMed ID: 11858905
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
    Schmitz FJ, Schwarz S, Milatovic D, Verhoef J, Fluit AC.
    J Antimicrob Chemother; 2002 Jul; 50(1):145-8. PubMed ID: 12096026
    [No Abstract] [Full Text] [Related]

  • 3. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).
    Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D.
    Braz J Infect Dis; 2003 Feb; 7(1):44-61. PubMed ID: 12807691
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
    Dubois J, St -Pierre C.
    Diagn Microbiol Infect Dis; 2001 Feb; 40(1-2):35-40. PubMed ID: 11448561
    [Abstract] [Full Text] [Related]

  • 5. Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
    Nilius AM, Hensey-Rudloff DM, Reimann MA, Flamm RK.
    J Antimicrob Chemother; 2002 May; 49(5):831-6. PubMed ID: 12003979
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Brueggemann AB, Doern GV, Huynh HK, Wingert EM, Rhomberg PR.
    Antimicrob Agents Chemother; 2000 Feb; 44(2):447-9. PubMed ID: 10639382
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of the ketolide ABT-773.
    Barry AL, Fuchs PC, Brown SD.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
    [Abstract] [Full Text] [Related]

  • 8. Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies.
    Low DE, Brown S, Felmingham D.
    Clin Microbiol Infect; 2004 Jan; 10(1):27-36. PubMed ID: 14706083
    [Abstract] [Full Text] [Related]

  • 9. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F, Carnegy F, Willcock J, Amyes S.
    J Antimicrob Chemother; 2004 May 17; 53(5):793-6. PubMed ID: 15056640
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H, Chen L, Chen X, Jia X, Li N, Liu W, Tong H, Xiang R, Zhang F, Zhao H, Zhang J, Xu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan 17; 39(1):30-7. PubMed ID: 26792053
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.